Robert J Mayer

Robert J Mayer

UNVERIFIED PROFILE

Are you Robert J Mayer?   Register this Author

Register author
Robert J Mayer

Robert J Mayer

Publications by authors named "Robert J Mayer"

Are you Robert J Mayer?   Register this Author

100Publications

2300Reads

22Profile Views

Ambident Reactivity of Phenolate Anions Revisited: A Quantitative Approach to Phenolate Reactivities.

J Org Chem 2019 Jul 26;84(14):8837-8858. Epub 2019 Jun 26.

Department Chemie , Ludwig-Maximilians-Universität München , Butenandtstr. 5-13 , 81377 München , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.9b01485DOI Listing
July 2019

Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.

Eur J Cancer 2019 Apr 1;111:82-93. Epub 2019 Mar 1.

Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.01.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436990PMC
April 2019

Biomimetic Approach Toward Enterocin and Deoxyenterocin.

J Org Chem 2019 Feb 18;84(3):1162-1175. Epub 2019 Jan 18.

Department of Chemistry , Ludwig-Maximilians-Universität München , Butenandtstraße 5-13 , 81377 München , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.joc.8b02273DOI Listing
February 2019

Nucleophilic Reactivities of Bleach Reagents.

Org Lett 2018 05 9;20(10):2816-2820. Epub 2018 May 9.

Department Chemie , Ludwig-Maximilians-Universität München , Butenandtstraße 5-13 , 81377 München , Germany.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acs.orglett.8b00645
Publisher Site
http://dx.doi.org/10.1021/acs.orglett.8b00645DOI Listing
May 2018

Which Factors Control the Nucleophilic Reactivities of Enamines?

Chemistry 2018 Apr 25;24(22):5901-5910. Epub 2018 Mar 25.

Department Chemie, Ludwig-Maximilians-Universität München, Butenandtstraße 5-13, 81377, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/chem.201705962DOI Listing
April 2018

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2018 04 28;36(11):1112-1120. Epub 2018 Feb 28.

Temidayo Fadelu, Sui Zhang, Robert J. Mayer, Shuji Ogino, Kimmie Ng, Jeffrey Meyerhardt, and Charles S. Fuchs, Dana-Farber/Partners CancerCare; Shuji Ogino, Kana Wu, Walter Willett, and Edward Giovannucci, Harvard TH Chan School of Public Health; Shuji Ogino, Edward Giovannucci, and Ying Bao, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham; Michael Messino, Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al B. Benson, Robert H Lurie Comprehensive Cancer Center, Northwestern University; Hedy L. Kindler, University of Chicago Comprehensive Cancer, Chicago, IL; Daniel M. Atienza, Virginia Oncology Associates, Norfolk, VA; Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA; and Charles S. Fuchs, Yale Cancer Center, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891130PMC
April 2018

Integrated safety summary for trifluridine/tipiracil (TAS-102).

Anticancer Drugs 2018 01;29(1):89-96

Division of Digestive Endoscopy and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000554DOI Listing
January 2018

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

J Clin Oncol 2017 Nov 4;35(32):3671-3677. Epub 2017 Oct 4.

Charles S. Fuchs, Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT; Charles S. Fuchs, Peter C. Enzinger, Jeffrey Meyerhardt, and Robert J. Mayer, Dana-Farber/Partners CancerCare; Harvey J. Mamon and Richard S. Swanson, Brigham and Women's Hospital, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University; Christopher G. Willett, Duke Cancer Institute, Duke University Medical Center, Durham; Joel E. Tepper, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC; Daniel G. Haller, University of Pennsylvania, Philadelphia, PA; Tomislav Dragovich, Banner MD Anderson Cancer Center, Gilbert; Leonard L. Gunderson, Mayo Clinic, Scottsdale, AZ; Steven R. Alberts, Mayo Clinic, Rochester, MN; Georg A. Bjarnason, Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Richard M. Goldberg and Kristen Ciombor, Ohio State University, James Cancer Hospital, Columbus, OH; Alan P. Venook, University of California at San Francisco, San Francisco, CA; David Ilson and Eileen O'Reilly, Memorial Sloan Kettering Cancer Center, New York, NY; and David J. Berg, University of Iowa/Holden Comprehensive Cancer Center, Iowa City, IA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.74.2130
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.74.2130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678342PMC
November 2017

Solvation Accounts for the Counterintuitive Nucleophilicity Ordering of Peroxide Anions.

Angew Chem Int Ed Engl 2017 10 18;56(43):13279-13282. Epub 2017 Sep 18.

Department Chemie, Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, 81377, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/anie.201707086DOI Listing
October 2017

Development and Validation of the PREMM Model for Comprehensive Risk Assessment of Lynch Syndrome.

J Clin Oncol 2017 Jul 10;35(19):2165-2172. Epub 2017 May 10.

Fay Kastrinos and Ashley McFarland, Columbia University Medical Center, New York, NY; Hajime Uno, Chinedu Ukaegbu, Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Carmelita Alvero, Harvard T.H. Chan School of Public Health; Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Ewout W. Steyerberg, University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.6120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493047PMC
July 2017

Reply to L. Casadaban et al.

J Clin Oncol 2017 04 23;35(12):1373-1374. Epub 2017 Jan 23.

Donna Niedzwiecki, Duke University, Durham, NC; Wendy L. Frankel, The Ohio State University, Columbus, OH; Alan P. Venook, University of California, San Francisco, San Francisco, CA; Xing Ye, Duke University, Durham, NC; Paula N. Friedman, Northwestern University, Chicago, IL; Richard M. Goldberg, The Ohio State University, Columbus, OH; Robert J. Mayer, Dana-Farber Cancer Institute, Boston, MA; Thomas A. Colacchio, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Jude Marie Mulligan, Timothy S. Davison, Eamonn O'Brien, and Peter Kerr, Almac Diagnostics, Craigavon, United Kingdom; Patrick G. Johnston, Queen's University, Belfast, United Kingdom; Richard D. Kennedy and D. Paul Harkin, Almac Diagnostics, Craigavon, United Kingdom; Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA; Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA; Robert S. Warren, University of California, San Francisco, San Francisco, CA; and Federico Innocenti, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.71.2646
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.71.2646DOI Listing
April 2017

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

J Clin Oncol 2017 Apr 30;35(10):1086-1095. Epub 2017 Jan 30.

Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Chinedu I. Ukaegbu, Lauren K. Brais, Philip G. McNamara, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Brian A. Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, and Richard J. Wenstrup, Myriad Genetics, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455355PMC
April 2017

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance).

J Clin Oncol 2016 09 18;34(25):3047-53. Epub 2016 Jul 18.

Donna Niedzwiecki and Xing Ye, Duke University, Durham; Federico Innocenti, University of North Carolina at Chapel Hill, Chapel Hill, NC; Wendy L. Frankel and Richard M. Goldberg, The Ohio State University, Columbus, OH; Alan P. Venook and Robert S. Warren, University of California-San Francisco, San Francisco, CA; Paula N. Friedman, The University of Chicago, Chicago, IL; Robert J. Mayer, Dana-Farber Cancer Institute; Monica M. Bertagnolli, Brigham and Women's Hospital, Boston, MA; Thomas Anthony Colacchio, Dartmouth-Hitchcock Medical Center, Lebanon, NH; Jude Marie Mulligan, Timothy S. Davison, Eamonn O'Brien, Peter Kerr, Richard D. Kennedy, and D. Paul Harkin, Almac Diagnostics, Craigavon; Patrick G. Johnston, Queen's University, Belfast, Northern Ireland; and Richard L. Schilsky, American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.4699DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012711PMC
September 2016

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers.

J Clin Oncol 2016 08 5;34(23):2736-42. Epub 2016 Jul 5.

Peter C. Enzinger and Robert J. Mayer, Dana-Farber Cancer Institute, Harvard Medical School, and Alliance for Clinical Trials in Oncology, Boston, MA; Barbara Ann Burtness and Steven J. Cohen, Fox Chase Cancer Center; Barbara Ann Burtness, Steven J. Cohen, and Al Bowen Benson III, Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group, Philadelphia, PA; Donna Niedzwiecki, Xing Ye, and Kathe Douglas, Alliance Statistics and Data Center, Duke University, Durham, NC; David H. Ilson, Memorial Sloan Kettering Cancer Center and Alliance for Clinical Trials in Oncology, New York, NY; Victoria Meucci Villaflor, University of Chicago Medicine and Alliance for Clinical Trials in Oncology; Al Bowen Benson III, Northwestern University Feinberg School of Medicine, Chicago, IL; Alan Venook, University of California San Francisco Helen Diller Family Comprehensive Cancer Center and Alliance for Clinical Trials in Oncology, San Francisco, CA; and Richard M. Goldberg, Ohio State University James Comprehensive Cancer Center and Alliance for Clinical Trials in Oncology, Columbus, OH.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2016/06/30/JCO.2015.65
Web Search
http://dx.doi.org/10.1200/JCO.2015.65.5092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019745PMC
August 2016

Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

Cancer Chemother Pharmacol 2016 Feb;77(2):439

Sarah Cannon Research Institute/Florida Cancer Specialists, 600 N. Cattlemen Road, Suite 200, Sarasota, FL, 34232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2890-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969883PMC
February 2016

Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2015 Nov 17;33(31):3598-607. Epub 2015 Aug 17.

Brendan J. Guercio, Shuji Ogino, and Edward L. Giovannucci, Harvard Medical School; Kaori Sato, Robert J. Mayer, Shuji Ogino, Jeffrey A. Meyerhardt, and Charles S. Fuchs, Dana-Farber Cancer Institute; Frank B. Hu, Shuji Ogino, Kana Wu, Walter C. Willett, and Edward L. Giovannucci, Harvard T.H. Chan School of Public Health; Shuji Ogino and Edward L. Giovannucci, Brigham and Women's Hospital, Boston, MA; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al Benson, Northwestern University; Hedy Kindler, University of Chicago, Chicago, IL; Daniel Atienza, Virginia Oncology Associates, Norfolk, VA; Donna Niedzwiecki and Xing Ye, Duke University Medical Center, Durham; Michael Messino, Southeast Cancer Control Consortium, Mission Hospitals, Asheville, NC; and Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.5062DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622099PMC
November 2015

Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.

Cancer Chemother Pharmacol 2015 Nov 14;76(5):925-32. Epub 2015 Sep 14.

Sarah Cannon Research Institute/Florida Cancer Specialists, 600 N. Cattlemen Road, Suite 200, Sarasota, FL, 34232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2850-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612319PMC
November 2015

Colorectal Cancer Screening, Version 1.2015.

J Natl Compr Canc Netw 2015 Aug;13(8):959-68; quiz 968

From Duke Cancer Institute; Huntsman Cancer Institute at the University of Utah; University of Colorado Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; Hereditary Colon Cancer Foundation; University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Roswell Park Cancer Institute; Stanford Cancer Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UC San Diego Moores Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Moffitt Cancer Center; Mayo Clinic Cancer Center; Fred & Pamela Buffett Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Vanderbilt-Ingram Cancer Center; University of Michigan Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Fox Chase Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/13/8/959.full.pdf
Web Search
August 2015

Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

N Engl J Med 2015 May;372(20):1909-19

From the Dana-Farber Cancer Institute, Boston (R.J.M, J.M.C.); University Hospitals, Leuven and KU Leuven, Leuven (E.V.C., H.P.), and Universitaire Ziekenhuizen Antwerp, Edegem (M.P.) - all in Belgium; University of Pisa, Pisa (A.F.), IRCCS Azienda Ospedaliera Universitaria San Martino-Istituto Nazionale per la Ricerca Sul Cancro, Genoa (A.S.), and the Fondazione Poliambulanza Istituto Ospedaliero, Brescia (A.Z.) - all in Italy; National Cancer Center Hospital East, Chiba (T.Y., A.O.), Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo (N.M.), Shizuoka Cancer Center, Shizuoka (K.Y.), National Cancer Center Hospital, Tokyo (Y.S.), Hokkaido University Hospital, Hokkaido (Y.K.), and Taiho Pharmaceutical, Tokyo (M.I.) - all in Japan; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Seville (R.G.-C.), and Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona (J.T.) - all in Spain; Centre Eugène Marquis, Rennes, France (E.B.); Royal Melbourne Hospital, Melbourne, VIC, Australia (B.T.); University of Southern California Norris Comprehensive Cancer Center, Los Angeles (H.-J.L.); Yale Cancer Center, New Haven, CT (H.H.); Taiho Oncology, Princeton, NJ (F.B., H.M.); and Stathmi, New Hope, PA (L.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1414325DOI Listing
May 2015

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

J Natl Cancer Inst 2015 Jan 27;107(1):345. Epub 2014 Nov 27.

: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, JAM, KS, JAC, RJM, SO, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (ATC, ELG, CSF); Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (PLS); Hopital du Sacre-Coeur de Montreal, Universite de Montreal, Quebec, Canada (RW); Edward Cancer Center, Naperville, IL (AH); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG); Division of Medical Oncology, University of California at San Francisco, San Francisco, CA (APV); Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, ELG) and Department of Nutrition (ELG), Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271076PMC
January 2015

Progress against GI cancer during the American Society of Clinical Oncology's first 50 years.

J Clin Oncol 2014 May 21;32(15):1521-30. Epub 2014 Apr 21.

American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.4121DOI Listing
May 2014

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

J Natl Cancer Inst 2013 Dec 14;105(23):1789-98. Epub 2013 Nov 14.

Affiliations of authors: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (SO, XL, YI, MY, NJM, KN, RJM, JAM, CSF); Department of Pathology (SO), Channing Division of Network Medicine, Department of Medicine (DS, CSF), and Department of Surgery (MMB), Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, DS) and Department of Biostatistics (DS) , Harvard School of Public Health, Boston, MA; Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Hôpital du Sacré-Coeur de Montréal, Montreal, Canada (RW); Loyola University Stritch School of Medicine, Maywood, IL (AH); current: Edward Cancer Center, Naperville, IL (AH); Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (RBM); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848984PMC
December 2013

Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803.

Clin Cancer Res 2013 Oct 27;19(20):5777-87. Epub 2013 Aug 27.

Authors' Affiliations: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Department of Biostatistics and Bioinformatics, Alliance Statistics and Data Center, Duke University Medical Center, Durham, North Carolina; Dana-Farber Cancer Institute; Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, Massachusetts; The Ohio State University, Columbus, Ohio; National Cancer Institute, Bethesda, Maryland; and Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0351DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122229PMC
October 2013

Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors.

Cancer Chemother Pharmacol 2013 May 9;71(5):1241-6. Epub 2013 Mar 9.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-013-2118-9
Publisher Site
http://dx.doi.org/10.1007/s00280-013-2118-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029418PMC
May 2013

Reply to A. Grothey et al and R.S. Midgley et al.

Authors:
Robert J Mayer

J Clin Oncol 2013 Apr;31(12):1612-3

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.8859DOI Listing
April 2013

The Genus Cladophora Kützing (Ulvophyceae) as a Globally Distributed Ecological Engineer.

J Phycol 2013 Feb 11;49(1):1-17. Epub 2013 Jan 11.

Department of Botany, University of Wisconsin-Madison, 430 Lincoln Drive, Madison, Wisconsin, 53706, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jpy.12025DOI Listing
February 2013

Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months.

Pancreatology 2012 Jan-Feb;12(1):35-8. Epub 2012 Jan 3.

Department of Imaging, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2012.01.001DOI Listing
November 2012

Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought.

Authors:
Robert J Mayer

J Clin Oncol 2012 Sep 20;30(27):3325-7. Epub 2012 Aug 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.1949DOI Listing
September 2012

Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians.

Acad Med 2012 Jul;87(7):845-52

Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/ACM.0b013e318258338dDOI Listing
July 2012

A step forward in the treatment of advanced biliary tract cancer.

N Engl J Med 2010 Apr;362(14):1335-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1001183DOI Listing
April 2010

The American Society of Clinical Oncology Cancer Foundation Grants Program: a 25-year report and a look toward the future.

J Clin Oncol 2010 Mar 22;28(9):1616-21. Epub 2010 Feb 22.

American Society of Clinical Oncology Cancer Foundation, Alexandria, VA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.4621DOI Listing
March 2010

By the way, doctor. We have screening tests for other cancers. How about pancreatic cancer?

Authors:
Robert J Mayer

Harv Health Lett 2009 May;34(7)

View Article

Download full-text PDF

Source
May 2009

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.

J Clin Oncol 2009 Mar 12;27(7):1116-21. Epub 2009 Jan 12.

Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Mail Stop 426, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.19.6857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667813PMC
March 2009

Targeted therapy for advanced colorectal cancer--more is not always better.

Authors:
Robert J Mayer

N Engl J Med 2009 Feb;360(6):623-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe0809343DOI Listing
February 2009

Systemic treatment of colorectal cancer.

Gastroenterology 2008 May;134(5):1296-310

Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2008.02.098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2528832PMC
May 2008

By the way, doctor. Cancer of the small intestine.

Authors:
Robert J Mayer

Harv Health Lett 2008 May;33(7)

View Article

Download full-text PDF

Source
May 2008

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.

JAMA 2008 Apr;299(16):1914-21

Department of Gastrointestinal Medical Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Mail Stop 426, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.299.16.1914DOI Listing
April 2008

Adjuvant treatment of colorectal cancer.

CA Cancer J Clin 2007 May-Jun;57(3):168-85

Dana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
August 2007

The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.

Gastroenterology 2007 Jan 20;132(1):127-38. Epub 2006 Sep 20.

Division of Gastroenterology, Department of Internal Medicine and Baylor Charles A. Sammons Cancer Center, Baylor University Medical Center, 3500 Gaston Avenue, Dallas, TX 75246, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2006.09.018DOI Listing
January 2007

Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease.

Gastroenterol Clin North Am 2006 Sep;35(3):713-27

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gtc.2006.07.006DOI Listing
September 2006

Fifty years of clinical research by the leukemia committee of the cancer and leukemia group B.

Clin Cancer Res 2006 Jun;12(11 Pt 2):3556s-63s

Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-9001DOI Listing
June 2006

Cancer and leukemia group B gastrointestinal cancer committee.

Clin Cancer Res 2006 Jun;12(11 Pt 2):3589s-95s

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-9004DOI Listing
June 2006